LUIS CARLOS LÓPEZ GARCÍA-rekin lankidetzan egindako argitalpenak (9)

2024

  1. 4-Hydroxybenzoic acid rescues multisystemic disease and perinatal lethality in a mouse model of mitochondrial disease

    Cell Reports, Vol. 43, Núm. 5

  2. Oral β-RA induces metabolic rewiring leading to the rescue of diet-induced obesity

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 7

2022

  1. The Q-junction and the inflammatory response are critical pathological and therapeutic factors in CoQ deficiency

    Redox Biology, Vol. 55

2021

  1. Animal models of coenzyme q deficiency: Mechanistic and translational learnings

    Antioxidants, Vol. 10, Núm. 11

  2. Metabolic targets of coenzyme q10 in mitochondria

    Antioxidants, Vol. 10, Núm. 4

  3. β-RA Targets Mitochondrial Metabolism and Adipogenesis, Leading to Therapeutic Benefits against CoQ Deficiency and Age-Related Overweight

    Biomedicines, Vol. 9, Núm. 10

2020

  1. Coenzyme Q10 modulates sulfide metabolism and links the mitochondrial respiratory chain to pathways associated to one carbon metabolism

    Human Molecular Genetics, Vol. 29, Núm. 19, pp. 3296-3311

2019

  1. Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease

    EBioMedicine, Vol. 42, pp. 511-523

  2. The paradox of coenzyme Q10 in aging

    Nutrients, Vol. 11, Núm. 9